Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
35.68
-2.00 (-5.31%)
Feb 27, 2026, 4:00 PM EST - Market closed
Vericel Employees
Vericel had 357 employees as of December 31, 2024. The number of employees increased by 43 or 13.69% compared to the previous year.
Employees
357
Change (1Y)
43
Growth (1Y)
13.69%
Revenue / Employee
$773,835
Profits / Employee
$46,269
Market Cap
1.81B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 1,372 |
| Recursion Pharmaceuticals | 800 |
| Agios Pharmaceuticals | 540 |
| Syndax Pharmaceuticals | 270 |
| Aurinia Pharmaceuticals | 130 |
| Pharvaris | 118 |
| Enliven Therapeutics | 65 |
| Nektar Therapeutics | 61 |
VCEL News
- 2 days ago - Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 27 days ago - Madison Small Cap Fund Q4 2025: Buys, Sells, And Standouts - Seeking Alpha
- 6 weeks ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 6 weeks ago - Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Vericel Announces Preliminary 2025 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 - GlobeNewsWire
- 3 months ago - Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025 - GlobeNewsWire